Rathi Prasad, PhD

Centre for Endocrinology, William Harvey Research Institute, Queen Mary University of London, London, UK
London, United Kingdom

Disclosure information not submitted.

Presentation(s):

• SUN-493 - Sphingosine Kinase 2 (SPHK2) Inhibition as A Therapeutic Strategy for Adrenocortical Carcinoma (ACC)

  Sunday, June 14, 2026
  9:00 AM - 4:00 PM CT